Option chain shows key data for LadRx's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for LadRx.

LadRx (OTC:LADX) Stock, Option Chain

LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.

LadRx Corp

Press Releases

LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License

Comments

LadRx

LadRx (LADX) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell